Abstract:Abstract Long-lived species Homo sapiens have evolved robust protection mechanisms against cancer by repressing telomerase and maintaining short telomeres, thereby delaying the onset of the majority of cancer types until post-reproductive age. Indeed, telomerase is silent in most differentiated human cells, predominantly due to the transcriptional repression of its catalytic component telomerase reverse transcriptase (TERT) gene. The lack of telomerase/TERT expression leads to progressive telomere erosion in dividing human cells, whereas critically shortened telomere length induces a permanent growth arrest stage named replicative senescence. TERT/telomerase activation has been experimentally shown to be essential to cellular immortalization and malignant transformation by stabilizing telomere length and erasing the senescence barrier. Consistently, TERT expression/telomerase activity is detectable in up to 90% of human primary cancers. Compelling evidence has also accumulated that TERT contributes to cancer development and progression via multiple activities beyond its canonical telomere-lengthening function. Given these key roles of telomerase and TERT in oncogenesis, great efforts have been made to decipher mechanisms underlying telomerase activation and TERT induction. In the last two decades since the TERT gene and promoter were cloned, the derepression of the TERT gene has been shown to be achieved typically at a transcriptional level through dysregulation of oncogenic factors or signaling, post-transcriptional/translational regulation and genomic amplification. However, advances in high-throughput next-generation sequencing technologies have prompted a revolution in cancer genomics, which leads to the recent discovery that genomic alterations take center stage in activating the TERT gene. In this review article, we summarize critical mechanisms activating TERT transcription, with special emphases on the contribution of TERT promoter mutations and structural alterations at the TERT locus, and briefly discuss the underlying implications of these genomic events-driven TERT hyperactivity in cancer initiation/progression and potential clinical applications as well.

Endoplasmic Reticulum Stress Activates Telomerase

Endoplasmic reticulum stress-a key guardian in cancer

Telomerase promotes formation of a telomere protective complex in cancer cells

Endoplasmic Reticulum Stress Regulates Tumor Growth and Anti-Tumor Immunity: a Promising Opportunity for Cancer Immunotherapy

Multiple Actions of Telomerase Reverse Transcriptase in Cell Death Regulation

Estrogen Activates Telomerase.

Transient Induction of Telomerase Expression Mediates Senescence and Reduces Tumorigenesis in Primary Fibroblasts.

Transcriptional Regulation of Telomerase Activity

Transmissible Endoplasmic Reticulum Stress: A Novel Perspective on Tumor Immunity

Telomerase Abrogates Aneuploidy-Induced Telomere Replication Stress, Senescence and Cell Depletion

Telomere Stress Potentiates STING-Dependent Anti-tumor Immunity

Ends end it via mitochondria: A telomere-dependent tumor suppressive mechanism acts during replicative crisis

miR-217 regulates normal and tumor cell fate following induction of Endoplasmic Reticulum Stress

Mitochondrial Trafficking and Processing of Telomerase RNA TERC

Human telomerase reverse transcriptase is a novel target of Hippo-YAP pathway

hTERT promotes cell adhesion and migration independent of telomerase activity

Intensive Inhibition of Htert Expression by a Ribozyme Induces Rapid Apoptosis of Cancer Cells Through a Telomere Length Independent Pathway

Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players

Telomerase Reverse Transcriptase Promotes Epithelial–mesenchymal Transition and Stem Cell-Like Traits in Cancer Cells

Cancer and ER stress: Mutual crosstalk between autophagy, oxidative stress and inflammatory response

Telomerase Reverse Transcriptase Potentially Promotes the Progression of Oral Squamous Cell Carcinoma Through Induction of Epithelial-Mesenchymal Transition.